Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa

Reports from the United States have demonstrated that elevated markers of microbial translocation from the gut may be found in chronic and advanced HIV-1 infection and are associated with an increase in immune activation. However, this phenomenon's role in HIV-1 disease in Africa is unknown. This study examined the longitudinal relationship between microbial translocation and circulating inflammatory cytokine responses in a cohort of people with varying rates of HIV-1 disease progression in Rakai, Uganda. Multiple markers for microbial translocation (lipopolysaccharide, endotoxin antibody, and sCD14) did not change significantly during HIV-1 disease progression. Moreover, circulating immunoreactive cytokine levels either decreased or remained virtually unchanged throughout disease progression. These data suggest that microbial translocation and its subsequent inflammatory immune response do not have a causal relationship with HIV-1 disease progression in Africa.

[1]  Steven Wolinsky,et al.  Microbial Translocation Is Associated with Increased Monocyte Activation and Dementia in AIDS Patients , 2008, PloS one.

[2]  O. Laeyendecker,et al.  The Effect of Viral Suppression on Cross-Sectional Incidence Testing in the Johns Hopkins Hospital Emergency Department , 2008, Journal of acquired immune deficiency syndromes.

[3]  Oliver Laeyendecker,et al.  Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. , 2008, The Journal of infectious diseases.

[4]  M. Clerici,et al.  Early Impairment of Gut Function and Gut Flora Supporting a Role for Alteration of Gastrointestinal Mucosa in Human Immunodeficiency Virus Pathogenesis , 2007, Journal of Clinical Microbiology.

[5]  N. Sewankambo,et al.  Survival of HIV-infected treatment-naive individuals with documented dates of seroconversion in Rakai, Uganda , 2007, AIDS.

[6]  J. Brenchley,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Retrovirology.

[7]  L. Lopalco,et al.  Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. , 2006, Blood.

[8]  D. Douek,et al.  HIV disease: fallout from a mucosal catastrophe? , 2006, Nature Immunology.

[9]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[10]  O. Laeyendecker,et al.  Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. , 2005, The Journal of infectious diseases.

[11]  Mario Roederer,et al.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection , 2005, Nature.

[12]  J. Flamm,et al.  Severe CD4+ T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy , 2003, Journal of Virology.

[13]  D. Douek.  Disrupting T-cell homeostasis: how HIV-1 infection causes disease. , 2003, AIDS reviews.

[14]  P. Kazembe,et al.  Peripheral blood cell-specific cytokines in persons with untreated HIV infection in Malawi, Africa. , 2002, AIDS research and human retroviruses.

[15]  K. Olkiewicz,et al.  The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease , 2002, Journal of endotoxin research.

[16]  H. Schuitemaker,et al.  T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock , 2000, Nature Immunology.

[17]  J. Margolick,et al.  The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults. , 1998, The Journal of infectious diseases.

[18]  R P Johnson,et al.  Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. , 1998, Science.

[19]  M. Clerici,et al.  Immunological activation markers in the serum of African and European HIV‐seropositive and seronegative individuals , 1996, AIDS.

[20]  J. Reuben,et al.  Type 1 and type 2 cytokine profiles in children exposed to or infected with vertically transmitted human immunodeficiency virus , 1996, Clinical and diagnostic laboratory immunology.

[21]  M. Daucher,et al.  Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Z. Bentwich,et al.  Immune activation is a dominant factor in the pathogenesis of African AIDS. , 1995, Immunology today.

[23]  J. Margolick,et al.  Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. , 1995, The New England journal of medicine.

[24]  N. Sewankambo,et al.  Incidence of HIV-1 infection in a rural region of Uganda , 1994, BMJ.

[25]  A. Fauci,et al.  Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection. , 1987, JAMA.

[26]  L. C. Norins,et al.  Natural Human Antibodies to Gram-Negative Bacteria: Immunoglobulins G, A, and M , 1966, Science.